NCT04418401 2026-02-17
CISLD-8
Zhejiang University
Phase 1 Completed
Clinical Trials
5 trialsNCT05348811 2026-01-06
HAIC Combined With Donafenib and Sintilimab for Unresectable ICC
Zhongda Hospital
Phase 2 Completed
NCT05262959 2024-08-13
A Single Center Study of Donafenib Combined With PD-1 + TACE in the First-line Treatment of aHCC
Shanghai Zhongshan Hospital
Phase 2 Completed
NCT02870582 2022-11-29
Donafenib for Previously Treated Metastatic Colorectal Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 3 Completed
NCT02489916 2016-01-05
Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2 Completed